International Patent: LECTINS FOR USE IN METHODS OF IMPROVING THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN CANCER

GENEVA, Sept. 24 -- AETHLON MEDICAL, INC. filed a patent application (US2026/019778) for “LECTINS FOR USE IN METHODS OF IMPROVING THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN CANCER”. With publication no. WO/2026/198688, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/16

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....